AbCelleras stock surged following successful trials of its drug / Photo: AbCellera
Small Caps·
Mid-cap biotech stocks soared on the back of successful trials of a hot flash treatment
Last week was golds best since January / Photo: Unsplash / Zlataky
News·
The price of gold rose above $4,400. Citadel identified a rare combination of factors driving the rise
Sionnas stock plummeted after the failure of trials for a cystic fibrosis drug / Photo: LinkedIn/Sionna Therapeutics
Small Caps·
Biotech firm Sionna unexpectedly failed its drug trials and lost 90% of its value in a single day
Oil prices rose after Trump took a tougher stance toward Iran / Photo: Boukhatala Chamseddine / Shutterstock
News·
Brent crude has approached $90. An analyst warned of the risk of a price spike as early as next week
News·
Morning in New York: Stock Indices Near All-Time Highs
News·
Intel expanded its stock offering and raised $20 billion
News·
A "Glass" iPhone Is Coming. Apple Will Radically Revamp Its Design in 2027 — Bloomberg
Small Caps·
AI-Driven Investing: Which Small-Cap Funds Outperformed the Russell 2000?
Stock Screener
Buy
Sell
Go to section
Guru Portfolios

Track the investments of top funds and market legends

‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
Go to section
Small Caps
DoubleVerify helps companies to measure the effectiveness of their advertising / Photo: Facebook / NYSE
Small Caps·
Digital media measurement firm DoubleVerify to be bought by Nielsen; stock at 1y high
Small Caps·
Small cap Dream Finders to acquire Beazer, forming sixth-largest home builder in U.S.
Small Caps·
Small caps last week: SolarEdge guidance, Bitdeer contract, Replimune nears approval
Small Caps·
Papa John's hits 14-year low after sales shrink again, company cuts 2026 outlook
Small Caps·
How Lindblad built a business taking travelers to the ends of the Earth
Go to section

Investment and Finance News